Evidence map›Paper›PMID 32316312›Full record

ArticleInternational journal of molecular sciences2020

Cost Effective Use of a Thiosulfinate-Enriched

Jose Manuel Perez-Ortiz, Eva Maria Galan-Moya, Miguel Angel de la Cruz-Morcillo, Juan Francisco Rodriguez, Ignacio Gracia, Maria Teresa Garcia, Francisco Javier Redondo-Calvo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Effect of Combined Grape Seed (International journal of molecular sciences · 2026
    Article
  2. Review
  3. EvaluatingBiomedicines · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Thiosulfinate-EnrichedInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Phytochemical Analysis and In Vitro Effects ofMolecules (Basel, Switzerland) · 2021
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jose Manuel Perez-OrtizTranslational Research Unit, Hospital General Universitario de Ciudad Real, 13004 Ciudad Real, Spain.ORCID 0000-0002-3588-6273
Eva Maria Galan-MoyaTranslational Research Unit, Hospital General Universitario de Ciudad Real, 13004 Ciudad Real, Spain.ORCID 0000-0001-5758-7592
Miguel Angel de la Cruz-MorcilloTranslational Research Unit, Hospital General Universitario de Ciudad Real, 13004 Ciudad Real, Spain.
Juan Francisco RodriguezDepartment of Chemical Engineering, Institute of Chemical and Environmental Technology, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.ORCID 0000-0001-8838-1976
Ignacio GraciaDepartment of Chemical Engineering, Institute of Chemical and Environmental Technology, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.
Maria Teresa GarciaDepartment of Chemical Engineering, Institute of Chemical and Environmental Technology, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.ORCID 0000-0001-8541-4285
Francisco Javier Redondo-CalvoTranslational Research Unit, Hospital General Universitario de Ciudad Real, 13004 Ciudad Real, Spain.
Hospital General Universitario de Ciudad Real · ESUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we sought to investigate the effects of a thiosulfinate-enriched garlic extract, co-administered with 5-fluorouracil (5-FU) or oxaliplatin chemotherapy, on the viability of colon cancer cells (Caco-2 and HT-29). We also addressed the economic feasibility of a new combined treatment of this thiosulfinate-enriched garlic extract, with oxaliplatin that could reduce the dosage and costs of a monotherapy. The thiosulfinate-enriched garlic extract not only enhanced the impact of 5-FU and oxaliplatin (500 µM) in decreasing Caco-2 and HT-29 viability, but also showed a higher effect than standard 5-FU and oxaliplatin chemotherapy as anti-cancer agents. These results provided evidences for the combination of lyophilized garlic extract and 5-FU or oxaliplatin as a novel chemotherapy regimen in colon cancer cells that may also reduce the clinical therapy costs.

Indexed as

Cost-Benefit AnalysisAntineoplastic AgentsCaco-2 CellsCell ProliferationCell SurvivalColonic NeoplasmsFluorouracilGarlicHT29 CellsHumansOxaliplatinPlant ExtractsThiosulfonic AcidsAntineoplastic AgentsFluorouracilOxaliplatinPlant ExtractsThiosulfonic AcidsallicinCaco-2chemotherapygarlicHT-29thiosulfinate

Identifiers

PMID32316312
PMCPMC7216288
OpenAlexW3017250056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.